本文翻译正在准备中。在此之前，我们暂时显示英文原文。
商业 · 2004/9/281 分钟阅读
Cumulative List of Exceptions and Alternative Procedures Approved by the Director of the Center for Biologics Evaluation and Research
本地自动翻译 · 来源原始语言
摘要
The Food and Drug Administration (FDA) is announcing the availability a cumulative list of exceptions and alternative procedures to requirements regarding blood, blood components, and blood products that have been approved by the Director of the Center for Biologics Evaluation and Research (CBER). Also, FDA is announcing that this list is posted on the Internet and it will be periodically updated.
来源原始语言: Federal Register — Food and Drug Administration打开原始公告 →